Evidence map›Paper›PMID 27038493›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2016

Local retention of antibodies in vivo with an injectable film embedded with a fluorogen-activating protein.

Wen Liu, Matthew J Saunders, Christina Bagia, Eric C Freeman, Yong Fan, Ellen S Gawalt, Alan S Waggoner, Wilson S Meng

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Wen LiuDivision of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA 15282, United States.
Matthew J SaundersMolecular Biosensor and Imaging Center and Carnegie Mellon University, Pittsburgh, PA 15213, United States; Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213, United States.
Christina BagiaDivision of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA 15282, United States.
Eric C FreemanCollege of Engineering, University of Georgia, Athens, GA 30602, United States.
Yong FanInstitute of Cellular Therapeutics, Allegheny-Singer Research Institute, Pittsburgh, PA 15212, United States; Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213, United States.
Ellen S GawaltDepartment of Chemistry and Biochemistry, Duquesne University, Pittsburgh, PA 15282, United States; McGowan Institute for Regenerative Medicine, Pittsburgh, PA 15213, United States.
Alan S WaggonerMolecular Biosensor and Imaging Center and Carnegie Mellon University, Pittsburgh, PA 15213, United States; Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213, United States.
Wilson S MengDivision of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA 15282, United States. Electronic address: meng@duq.edu.
Duquesne University · USCarnegie Mellon University · USImaging Center · USUniversity of Georgia · US

Funding

Induction of allogeneic tolerance with bioengineered thymus organoidsR01AI123392 · NIAID · ALLEGHENY-SINGER RESEARCH INSTITUTE · PI FAN, YONG · 2016 to 2019
$1.5M
A Biomaterial Approach to Attenuate Rejection of Skin AllograftsR21AI113000 · NIAID · DUQUESNE UNIVERSITY · PI MENG, WILSON S · 2014 to 2015
$320k
NIAID NIH HHS R01 AI123392NIAID NIH HHS R21 AI113000
6 · The paper itself

Abstract

Herein we report an injectable film by which antibodies can be localized in vivo. The system builds upon a bifunctional polypeptide consisting of a fluorogen-activating protein (FAP) and a β-fibrillizing peptide (βFP). The FAP domain generates fluorescence that reflects IgG binding sites conferred by Protein A/G (pAG) conjugated with the fluorogen malachite green (MG). A film is generated by mixing these proteins with molar excess of EAK16-II, a βFP that forms β-sheet fibrils at high salt concentrations. The IgG-binding, fluorogenic film can be injected in vivo through conventional needled syringes. Confocal microscopic images and dose-response titration experiments showed that loading of IgG into the film was mediated by pAG(MG) bound to the FAP. Release of IgG in vitro was significantly delayed by the bioaffinity mechanism; 26% of the IgG were released from films embedded with pAG(MG) after five days, compared to close to 90% in films without pAG(MG). Computational simulations indicated that the release rate of IgG is governed by positive cooperativity due to pAG(MG). When injected into the subcutaneous space of mouse footpads, film-embedded IgG were retained locally, with distribution through the lymphatics impeded. The ability to track IgG binding sites and distribution simultaneously will aid the optimization of local antibody delivery systems.

Indexed as

Drug Delivery SystemsAnimalsBinding SitesFemaleFluorescent DyesImmunoglobulin GInjectionsMice, Inbred BALB CPeptidesProtein BindingRosaniline DyesFluorescent DyesImmunoglobulin Gmalachite greenPeptidesRosaniline DyesAntibody formulationBioaffinity filmControlled releaseDimerized light chain-5 (dL5)Draining lymph nodesEAK16Fluorescent imagingFluorogen-activating proteinMathematical simulationSelf-assembling peptideSingle-chain variable fragment

Identifiers

PMID27038493
PMCPMC5716469
OpenAlexW2316824680

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.